Soligenix
Soligenix is a New Jersey-based late-stage biopharmaceutical company that researches and develops novel vaccines for the treatment of cancer and rare diseases.
Business Model:
Revenue: $899k
Employees: 2-10
Industries / Tags:
Detailed Soligenix Information
Geographic Data
Address: 29 Emmons Drive
City: Princeton
State: NJ
Zip: 08540
Country: US
Financial Info
Stage:
grant
Raised Last:
$1M
Raised Total:$41M
Social
Metrics
2,460,457Website Global Rank
7,377Website Monthly Traffic
Twitter Followers
Description
Soligenix is a New Jersey-based late-stage biopharmaceutical company that researches and develops novel vaccines for the treatment of cancer and rare diseases.
Contact Phone:
+16095388200
Contact Email:
Soligenix went public on 12/13/2016 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
12/13/2016
Ticker Symbol:
SNGX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
